People | July 11, 2025
GlaxoSmithKline Pharmaceuticals appoints Vishwanath Swarup as Commercial Head - General Medicines
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Commercial production is expected to begin soon
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
Extended lab space for product development, customer demos, and training
Eylea 8 mg is the first and only anti-vascular endothelial growth factor (VEGF) treatment in the EU with treatment intervals of up to 6 months for both patients with nAMD and DME
Subscribe To Our Newsletter & Stay Updated
